Proton pump inhibitor
Proton pump inhibitors may be used to treat symptoms of Gastroesophageal Reflux (GERD).
Warning: long term use of PPIs is considered a risk factor for the development of SIBO (small intestinal bacterial overgrowth), which has symptoms like fatigue and brain fog that are quite similar to conditions Chronic fatigue syndrome.
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Costs and availability[edit | edit source]
List of proton pump inhibitors[edit | edit source]
Proton pump inhibitors include:
- Dexlansoprazole e.g., Dexilant, Kapidex
- Esomeprazole e.g., Nexium
- Pantoprazole e.g., Protonix
- Rabeprazole e.g., Aciphex
Systemic mastocytosis[edit | edit source]
Proton pump inhibitors for systematic mastocytosis (which is not the same as mast cell activation disorder) include:
See also[edit | edit source]
Learn more[edit | edit source]
- Proton pump inhibitors - drugs.com
References[edit | edit source]
- "List of Proton Pump Inhibitors + Uses, Side Effects". Drugs.com. Retrieved February 16, 2021.
- LO, WAI–KIT; CHAN, Walter W. (2013). "Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis". CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (11): 483–490.
- Su, Tingting; Lai, Sanchuan; Lee, Allen; He, Xingkang; Chen, Shujie (2018-01). "Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth". Journal of Gastroenterology. 53 (1): 27–36. doi:10.1007/s00535-017-1371-9. ISSN 1435-5922. PMID 28770351. Check date values in:
- "Medications for Systemic Mastocytosis". Drugs.com. Retrieved February 18, 2021.